Patients with migraines, rheumatoid arthritis and muscular dystrophy soon will be able to treat their ailments with medical marijuana in Connecticut.
The Legislature’s Regulation Review Committee unanimously voted Tuesday to expand the approved uses of medical marijuana for palliative care.
The state anticipates a “relatively significant increase” of patients joining the medical marijuana program as a result of these new uses, said Lora Rae Anderson, spokesman for the Department of Consumer Protection, which oversees the state’s medical marijuana program.
Click here to read the complete article
Emilie Munson ~ CTPost.com ~
